Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendon J Coventry

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal for Immunotherapy of Cancer|July 21, 2016
Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanomaBrendon J Coventry, Carrie A Lilly, Peter Hersey, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 20, 2004
Are cutaneous melanomas of specified thickness showing deeper levels of invasion at diagnosis?Colin G Luke, Brendon J Coventry, Erwin J Foster-Smith, et al.
Scientific Reports|August 12, 2018
On detection of periodicity in C-reactive protein (CRP) levelsMohsen Dorraki, Anahita Fouladzadeh, Stephen J Salamon, et al.
Frontiers in Immunology|October 24, 2022
Chronovaccination: Harnessing circadian rhythms to optimize immunisation strategiesClaire O Otasowie, Rachel Tanner, David W Ray, et al.
The Medical Journal of Australia|February 14, 2018
Updated evidence-based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanomaMichael J Sladden, Omgo E Nieweg, Julie Howle, et al.
Journal of Translational Medicine|December 2, 2009
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?Brendon J Coventry, Martin L Ashdown, Michael A Quinn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 15, 2019
Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center studyHidde M Kroon, Brendon J Coventry, Michael A Henderson, et al.
Cancer Research|May 19, 2006
Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse modelLe Minh Thai, Agatha Labrinidis, Shelley Hay, et al.
F1000Research|February 3, 2016
Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response RatesMartin L Ashdown, Andrew P Robinson, Steven L Yatomi-Clarke, et al.
Annals of Surgical Oncology|August 12, 2017
Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter StudyHidde M Kroon, Brendon J Coventry, Mitchell H Giles, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|July 21, 2016
Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanomaBrendon J Coventry, Carrie A Lilly, Peter Hersey, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 20, 2004
Are cutaneous melanomas of specified thickness showing deeper levels of invasion at diagnosis?Colin G Luke, Brendon J Coventry, Erwin J Foster-Smith, et al.
Scientific Reports|August 12, 2018
On detection of periodicity in C-reactive protein (CRP) levelsMohsen Dorraki, Anahita Fouladzadeh, Stephen J Salamon, et al.
Frontiers in Immunology|October 24, 2022
Chronovaccination: Harnessing circadian rhythms to optimize immunisation strategiesClaire O Otasowie, Rachel Tanner, David W Ray, et al.
The Medical Journal of Australia|February 14, 2018
Updated evidence-based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanomaMichael J Sladden, Omgo E Nieweg, Julie Howle, et al.
Journal of Translational Medicine|December 2, 2009
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?Brendon J Coventry, Martin L Ashdown, Michael A Quinn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 15, 2019
Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center studyHidde M Kroon, Brendon J Coventry, Michael A Henderson, et al.
Cancer Research|May 19, 2006
Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse modelLe Minh Thai, Agatha Labrinidis, Shelley Hay, et al.
F1000Research|February 3, 2016
Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response RatesMartin L Ashdown, Andrew P Robinson, Steven L Yatomi-Clarke, et al.
Annals of Surgical Oncology|August 12, 2017
Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter StudyHidde M Kroon, Brendon J Coventry, Mitchell H Giles, et al.
Pageof 5